Bookbuilding IPO | ₹315 Cr | Listing at NSE, BSE | Thu, Mar 11, 2004 - Thu, Mar 18, 2004 P
BIOCON IPO is a book build issue of ₹315.00 crores. The issue is entirely a fresh issue of 1.00 crore shares of ₹315.00 crore.
BIOCON IPO bidding started from Mar 11, 2004 and ended on Mar 18, 2004.
BIOCON IPO is set final issue price at ₹315 per share.
BOFA Securities India Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to for detailed Information.
IPO Open
Thu, Mar 11, 2004
IPO Close
Thu, Mar 18, 2004
Issue Price
₹315 per share
Market Cap (Pre-IPO)
₹3,150.00 Cr
| IPO Date | 11 to 18 Mar, 2004 |
| Listing Date | [.] |
| Face Value | ₹5 per share |
| Price Band | ₹270 to ₹315 |
| Issue Price | ₹315 per share |
| Lot Size | |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE, BSE |
| Total Issue Size | 1,00,00,000 shares (agg. up to ₹315 Cr) |
| Fresh Issue | 1,00,00,000 shares (agg. up to ₹315 Cr) |
| Share Holding Pre Issue | 9,00,00,000 shares |
| Share Holding Post Issue | 10,00,00,000 shares |
BIOCON IPO comprises a total issue size of 1,00,00,000 shares. Out of which, 60,00,000 (60.00%) are allocated to QIB, 15,00,000 (15.00%) allocated to NII 25,00,000 (25.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue |
|---|---|---|
| QIB Shares Offered | 60,00,000 | 60.00% |
| NII (HNI) Shares Offered | 15,00,000 | 15.00% |
| Retail Shares Offered | 25,00,000 | 25.00% |
| Total Shares Offered | 1,00,00,000 | 100.00% |
Incorporated in 1978, Biocon Limited is a Bengaluru-based biotechnology company engaged in biopharmaceuticals, enzymes, custom research, and clinical research services. The company manufactures APIs, specialty enzymes, and provides research and clinical trial solutions through its subsidiaries Syngene International and Clinigene International.
The company has a global presence across the United States, Europe, Japan, South America, and Southeast Asia. Its manufacturing and R&D facilities are located in Bengaluru, including fermentation and synthetic manufacturing units supported by proprietary technologies such as PlaFractor.
As of December 31, 2003, the company had 854 employees including scientists, researchers, and technical professionals.
Competitive Strengths:
| Period Ended | 31 Dec 2003 | 31 Mar 2003 | 31 Mar 2002 | 31 Mar 2001 |
|---|---|---|---|---|
| Assets | 403.62 | 272.33 | 208.62 | 129.77 |
| Total Income | 37,24,50,000.00 | 25,55,20,000.00 | 16,49,30,000.00 | 12,35,90,000.00 |
| Profit After Tax | 86.11 | 35.31 | 21.49 | 14.52 |
| NET Worth | 212.00 | 124.73 | 86.01 | 56.01 |
| Reserves and Surplus | 168.48 | 124.55 | 86.07 | 56.01 |
| Total Borrowing | 65.03 | 68.56 | 66.53 | 38.19 |
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Land | 18.40 |
| 2 | Buildings | 120.00 |
| 3 | Plant and Machinery (including machinery and equipment under erection) | 260.00 |
| 4 | Other Assets | 15.00 |
| Total | 413.40 |
| KPI | Dec 31, 2003 | Mar 31, 2003 |
|---|---|---|
| RoNW | 53.9% | 27.9% |
| Price to Book Value | 22.66 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 3.92 | 11.48 |
| P/E (x) | 80.29 | 27.44 |
| Promoter Holding | 68.38% | 61.53% |
| Market Cap | ₹3,150.00 Cr. |
The BIOCON IPO IPO subscription status. Full data available on IPOMatrix.com.
| Category | Subscription (times) | Shares Offered | Shares bid for | |
|---|---|---|---|---|
| Total | 32.47 | 1,00,00,000 | 32,46,67,550 | |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Marketing costs (Advertising expenses, roadshows) | 2.42 |
| 2 | Printing, Registrar costs, stamp duty, listing and Depository costs | 2.77 |
| 3 | Fees payable to BRLMs, CBRLM, domestic and international legal counsel to the underwriters and domestic legal counsel to the Company, auditors and financial advisors | 11.31 |
| Total | 16.50 |
BIOCON IPO is a main-board IPO of 1,00,00,000 equity shares of the face value of ₹5 aggregating up to ₹315 Crores. The issue is priced at ₹315 per share. The minimum order quantity is .
The IPO opens on Thu, Mar 11, 2004, and closes on Thu, Mar 18, 2004.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on NSE, BSE.
Zerodha customers can apply online in BIOCON IPO using UPI as a payment gateway. Zerodha customers can apply in BIOCON IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in BIOCON IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The BIOCON IPO opens on Thu, Mar 11, 2004 and closes on Thu, Mar 18, 2004.
BIOCON IPO lot size and the minimum order quantity is not available at this time. Please check again later.
You can apply in BIOCON IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for BIOCON IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the BIOCON IPO allotment status.
The BIOCON IPO listing date is not yet announced. The tentative date of listing is .
